IgE Profiles of Bermuda Grass Pollen Sensitised Patients Evaluated by Phleum Pratense Allergens Phl P 1, 2, 4, 5, 6 , 7, 11, 12

  • Rossi Renato E
    Allergy Unit, National Health Service, Rete di Allergologia, Regione Piemonte
  • Monasterolo Giorgio
    Dipartimento di Analisi Chimico-Cliniche e Microbiologia, Ospedali di Fossano e Savigliano
  • Prina Paolo
    Deparment of Otorhinolaryngology, Ospedale SS Annunziata
  • Coco Giuseppe
    Dipartimento di Analisi Chimico-Cliniche e Microbiologia, Ospedali di Fossano e Savigliano
  • Operti Daniela
    Dipartimento di Analisi Chimico-Cliniche e Microbiologia, Ospedali di Fossano e Savigliano
  • Rossi Lucilla
    Department of General Pathology, University of Genoa

この論文をさがす

抄録

Background: Despite the difference in geographical dominance of certain grasses, a high degree of allergenic similarity or cross-reactivity between Bermuda grass pollen (BGP) and timothy grass pollen (TGP) has been previously demonstrated.<br> The aim of the present study was to ascertain the sensitisation to TGP in 411 patients known for their reactivity to BGP extracts by analysing their reactivity to crude timothy pollen extract and timothy pollen purified allergens, establishing their specific IgE-profiles.<br> Methods: Using the immunoenzymatic CAP method we evaluated IgE-specific antibodies for BGP- and TGP- extracts and the timothy recombinant (r) and natural (n) allergens rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12.<br> Results: BGP-IgE positive patients (median = 8.0kUA/l, 2.8-22.2kUA/l 25th-75th percentile) simultaneously had IgE positive results for TGP (100% of subjects) (median = 48.9kUA/l, 19.8- > 100kUA/l 25th-75th percentile) and high prevalence of sensitization to 6/8 Phleum pratense allergens (Phl p 1, 2, 4, 5, 6, 11, markers of genuine sensitisation to TGP) other than profilin and calcium binding protein. More than 72% of BGP allergic patients were co-sensitised to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6. A decrease of total and specific IgE with patients' age was observed.<br> Conclusions: Our data show that all BGP-allergic patients simultaneously exhibit higher IgE antibody levels to recombinant and natural P. pratense allergens as well as to crude TGP extract. This suggests that when choosing an immunotherapeutic regimen for BGP-sensitised patients (after establishing their IgE profile via purified TGP-allergens), subcutaneous or sublingual TGP-extract vaccines in appropriate doses, in order to influence T epitope specificity, might be beneficial. Though extremely uncommon, in cases where a patient is exclusively BGP allergen-sensitised, BGP-extract therapy is the appropriate therapeutic response.<br>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (30)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ